358570 - GI Innovation, Inc.

358570 Summary
Biopharma
Stock Price & Overview
₩8,090 +470 (+6.17%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩8,090  ≈ US$6  ·  Market cap ₩0.5tn (≈ $373m)

Material matter affecting investment judgment (clinical trial plan amendment approved)

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항(임상시험계획변경승인) (GI108 제1/2a상 임상시험계획 한국식품의약품안전처 변경승인)